Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma

NCT03175939 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

263

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Cancer

Interventions

RADIATION: Radiotherapy
DRUG: Cisplatin
DRUG: 5-FU

Sponsor

Sun Yat-sen University